Fluid Biomed
PrivateLast Round
Series A
Dec 16, 2024
Total Funding Raised
$32.55M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Fluid Biomed operates in Healthcare & Life Sciences and is based in Calgary. Its latest recorded funding round was a Series A round in December 2024.
Fluid Biomed is a medical device company that develops a bioabsorbable, polymer-based stent called ReSolv™ to treat brain aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fluid Biomed Comparables
Compare Fluid Biomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amaranth Medical, Inc. | 87% | |
| Elixir Medical Corporation | 86% | |
| REVA Medical | 86% |
For institutional investors. Book with your work email.
Fluid Biomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 16, 2024 | ||||
| Seed | Aug 11, 2021 | ||||
| Pre Seed | Feb 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fluid Biomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAG Capital Partners | Series A |
| Wharton Alumni Angels | Seed |
| Amplitude Ventures | Series A |
| Amino Capital | Seed |
| LifeArc Ventures | Series A |
| ShangBay Capital | Series A, Seed |
| Innovate Calgary | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 99% MoM, reaching 1.9K.
- Jul 20, 2026
Open roles increased to 10, 2.5x the trailing average.
For institutional investors. Book with your work email.
Fluid Biomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fluid Biomed's valuation, stock price, and market status.
Is Fluid Biomed a public or private company?
Fluid Biomed is a private company.
What is the current stock price of Fluid Biomed?
Fluid Biomed is a private company, so its shares have no public market price. Caplight tracks Fluid Biomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fluid Biomed worth (valuation)?
Valuation information for Fluid Biomed is not publicly available.
Can I buy Fluid Biomed stock?
Fluid Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fluid Biomed's last funding round?
Fluid Biomed's most recent funding round was Series A on December 16, 2024.
Who are the main investors in Fluid Biomed?
Key investors in Fluid Biomed include Amplitude Ventures, ShangBay Capital, METIS Innovative.
Will Fluid Biomed IPO soon?
No public IPO plans have been announced for Fluid Biomed.
How can I track Fluid Biomed secondary market activity?
Caplight tracks bids, offers, and trades in Fluid Biomed's shares on secondary markets.